Beneficient (BENF) Stock Price & Analysis
Beneficient (BENF) rose 1.47% to USD 3.44 as of June 10, 2026 at 02:14 UTC, according to Nexqual real-time market data.
BENF last closed at USD 3.39; the session ranged USD 3.35–3.49 on volume of 12,179 shares. Market capitalization is $49.41M, with a 52-week range of USD 2.1–12.48 (NCM). Source: Nexqual, June 10, 2026 at 02:14 UTC.
Key Statistics (as of June 10, 2026 at 02:14 UTC)
| Price | USD 3.44 |
|---|---|
| Change | ▲ 1.47% (up) |
| Previous Close | USD 3.39 |
| Open | USD 3.45 |
| Day Range | USD 3.35 – 3.49 |
| 52-Week Range | USD 2.1 – 12.48 |
| Volume | 12,179 shares |
| Market Cap | $49.41M |
| Exchange | NCM |
Technical Analysis (BENF)
Nexqual's technical model rates BENF "SELL" based on 1 bullish and 4 bearish signals across 124 daily candles, as of June 10, 2026 at 02:14 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 49.09 (neutral) |
| vs SMA50 | Below (USD 3.46) |
| MACD | 0.03 (positive) |
Analyst Ratings (BENF)
Wall Street analysts rate BENF "None" based on 1 analysts, with a mean price target of USD 10 (range USD 10–10), per Nexqual as of June 10, 2026 at 02:14 UTC.
| Consensus Rating | None |
|---|---|
| Analyst Count | 1 |
| Mean Target | USD 10 |
| High Target | USD 10 |
| Low Target | USD 10 |
| Buy / Hold / Sell | 0 / 0 / 0 |
Earnings (BENF)
| Revenue Estimate | $202,000 |
|---|
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2025-12-31 | USD 0.04 vs est 0 ▲ beat |
| 2025-09-30 | USD -2.96 vs est 3.04 ▼ miss |
| 2025-06-30 | USD -57.52 vs est 8.8 ▼ miss |
| 2025-03-31 | USD -0.72 vs est -0.56 ▼ miss |
Source: Nexqual, June 10, 2026 at 02:14 UTC.
Financials & Fundamentals (BENF)
| Total Revenue | $90.14M |
|---|---|
| Revenue Growth (YoY) | +73.40% |
| Gross Margin | +95.94% |
| Operating Margin | +67.87% |
| Profit Margin | -6.25% |
| ROE | -14.91% |
| Debt / Equity | 486.17 |
| Current Ratio | 12.11 |
| Total Cash | $154.38M |
| Total Debt | $1.27B |
| Free Cash Flow | $421.32M |
Source: Nexqual, June 10, 2026 at 02:14 UTC.
Financial Health Score (BENF)
Nexqual rates Beneficient's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 02:14 UTC.
| Growth | Strong — Revenue +73% YoY (latest Q) |
|---|---|
| Profitability | Weak — Pre-revenue or very early stage |
| Balance Sheet | Weak — $154M cash vs $1.27B debt |
| Cash Flow | Solid — Operating cash flow $12M |
| Efficiency | Critical — ROE -15%, ROA 1.7% |
Ownership (BENF)
| Insider Ownership | +92.82% |
|---|---|
| Institutional Ownership | +3.96% |
| Shares Outstanding | 14.33M |
| Short % of Float | +11.99% |
Source: Nexqual, June 10, 2026 at 02:14 UTC.
Leadership (BENF)
Beneficient is led by James G. Silk (age 56), Interim Chief Executive Officer, per Nexqual as of June 10, 2026 at 02:14 UTC.
| Interim Chief Executive Officer | James G. Silk (age 56) |
|---|---|
| President of BFF, Chief Fiduciary Officer & Director | Derek L. Fletcher (age 56) |
| Chief Financial Officer | Gregory W. Ezell (age 49) |
| Chief Technology Officer | Maria S. Rutledge (age 48) |
| Director of Communication | Dan Callahan |
Major Backers & Investors (BENF)
Notable institutional backers of Beneficient include Fidelity, Morgan Stanley, according to Nexqual as of June 10, 2026 at 02:14 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Fidelity | 0.88% |
| Morgan Stanley | 0.17% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 2.68% |
| Geode Capital | 1.11% |
| State Street | 0.37% |
| BlackRock | 0.32% |
| Northern Trust | 0.22% |
Source: Nexqual, June 10, 2026 at 02:14 UTC.
From Beneficient's Latest SEC 10-K Filing (filed 2025-09-29)
Key Strengths & Strategy (as disclosed to the SEC)
- While Ben's financial products and services are presently primarily offered through Ben Liquidity and Ben Custody, Ben plans to expand its capabilities under Ben Custody and provide additional products and services through Ben Insurance, L.L.C. and its subsidiaries (collectively, "Ben Insurance Services") and Ben Markets L.L.C., including its subsidiaries ("Ben Markets") in the future.
- Ben Insurance Services plans to provide insurance products and services to certain "affiliates" (as defined in the Kansas Captive Insurance Act), including the Customer ExAlt Trusts, custody accounts and other trusts for which BFF serves as trustee or custodian, to cover risks attendant to the ownership, management and transfer of alternative assets and financings related to alternative asset transactions.
- The AltAccess platform is designed to ultimately be provided through a software as a service ("SaaS") model to multiple intermediaries, including commercial lenders, and to be accessed through an application programming interface ("API") for these intermediaries to deploy in their businesses.
- Ben's internal technology team programmed in the flexibility to allow Ben to deliver the AltAccess platform using a software as a service ("SaaS") provider model to multiple intermediaries who could source Customers and transactions for Ben to process through application programming interface ("API") options as a white label platform for these intermediaries to also deploy in their businesses.
Partnerships
- In order to achieve an optimized risk adjusted return and diversification under our OptimumAlt endowment model, operational economies of scale, improved margins and tangible book value for our shareholders, the Board has approved the launch of a plan (the "ExchangeTrust Product Plan") to complete up to $5 billion of fiduciary financings to Customer ExAlt Trusts through ExchangeTrust transactions.
- These solutions are made available to our target markets through our dedicated Originations group, which identifies and engages Customers in need of early liquidity and our General Partner Solutions ("GP Solutions") group, which is specifically focused on partnering with GPs navigating the myriad of options that exist for fund restructurings, limited partnership liquidity and primary commitments.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| NIVF | NewGenIvf Group Limited | USD 0.49 | ▼ 22.88% |
| VCIG | VCI Global Limited | USD 6.04 | ▼ 14.81% |
| TGL | Treasure Global Inc. | USD 4.06 | ▼ 7.52% |
| VSEE | VSee Health, Inc. | USD 0.16 | ▼ 1.19% |
| FRGT | Freight Technologies, Inc. | USD 4.5 | ▲ 6.64% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 02:14 UTC. This page is informational and not investment advice.